24 August 2020 : Laboratory Research
Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells
Jiansheng Zhong1ABE*, Jinli Zhang2AB, Xiaoyang Yu3BF, Xing Zhang1CD, Linping Dian1CDDOI: 10.12659/MSM.924922
Med Sci Monit 2020; 26:e924922
Figure 1 The expression of ETS1 and ABCB1 in K562 and K562/ADR cell lines. (A) Representative immunoblot analysis of ETS1 and ABCB1. (B) Relative protein expression of ETS1 in K562/ADR cell line (n=3). (C) Relative protein expression of ABCB1 in K562/ADR cell line (n=3). (D) Relative mRNA expression of ETS1 in K562/ADR cell line (n=3). (E) Relative mRNA expression of ABCB1 in K562/ADR cell line (n=3). *** P<0.001 vs. K562 cell line.